06.06.2013
![]()
DGAP-News: Celesio AG: The Celesio management board is complete again: Martin Fisher appointed COO
DGAP-News: Celesio AG / Key word(s): Change of Personnel
Celesio AG: The Celesio management board is complete again: Martin
Fisher appointed COO
06.06.2013 / 15:15
---------------------------------------------------------------------
The Celesio management board is complete again: Martin Fisher appointed COO
Stuttgart, 6 June 2013. The Celesio AG supervisory board has appointed
Martin Fisher (53) to the management board, which he will join by 1st
October 2013 the latest. In his most recent role Fisher was Head of Global
Supply Chain at Arysta Lifescience. Fisher will run Celesio's Operations
divisions comprising the group-wide responsibility for procurement, supply
chain management, quality management and regulations, as well as IT.
Celesio CEO Markus Pinger: 'We are very happy that Martin Fisher will
complete the Celesio management board. Martin Fisher has many years of
international experience in global supply chain management. The further
development of our logistics, procurement and IT activities is a vital
success factor in the integration of our retail and wholesale activities
and the creation of a completely integrated end-to-end business model.
This is the core of our strategic realignment.'
After completing his degree in the UK, British-born Martin Fisher worked at
several international companies such as Benckiser and Coty in leading
positions in the area of operations/supply chain/logistics. Prior to
joining Dairy Crest Group PLC in 2007 in the function of Group Operations
Director, he was Senior Vice President Supply, Developing Markets at
Reckitt Benckiser PLC from 2000. In 2009, Martin Fisher was appointed
Global Head, Supply Chain at Arysta.
Press contact
Dr Jens Schreiber, Celesio AG, +49 (0)711.5001-380
[email protected]
Rainer Berghausen, Celesio AG, +49 (0)711.5001-549
[email protected]
About Celesio Group
As a leading international trading company and provider of logistics and
services in the pharmaceutical and healthcare sector, Celesio takes a
proactive and preventive approach to ensuring that patients receive the
products and support that they require for optimum care. With 39,000
employees, we operate in 16 countries around the world. Every day, we serve
over 2 million customers - at 2,200 pharmacies of our own and 4,100
participants in our brand partnership schemes. With around 140 wholesale
branches, we supply approximately 65,000 pharmacies and hospitals every day
with up to 130,000 pharmaceutical products. Our services benefit a patient
pool of about 15 million per day.
End of Corporate News
---------------------------------------------------------------------
06.06.2013 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: Celesio AG
Neckartalstr. 155
70376 Stuttgart
Germany
Phone: +49 (0)711 5001-735
Fax: +49 (0)711 5001-740
E-mail: [email protected]
Internet: www.celesio.com
ISIN: DE000CLS1001
WKN: CLS100
Indices: MDAX
Listed: Regulierter Markt in Berlin, Düsseldorf, Frankfurt (Prime
Standard), München, Stuttgart; Freiverkehr in Hamburg,
Hannover; Terminbörse EUREX
End of News DGAP News-Service
---------------------------------------------------------------------
215261 06.06.2013
|